Skip to main content
Premium Trial:

Request an Annual Quote

Roche Diagnostics, PEPFAR Tackle HIV/AIDS in Africa

NEW YORK (GenomeWeb News) – Roche Diagnostics and the US President's Emergency Plan for AIDS Relief (PEPFAR) announced on Tuesday a public-private partnership aimed at improving the capabilities of laboratories in Africa in the area of HIV/AIDS training and knowledge.

The partnership is for five years, is valued at $12 million, and seeks to create "institutional capacity of regional and national partners by developing certification programs for laboratory technicians, strengthening pre-service curricula, and institutionalizing quality improvement in diagnostics services," the partners said in a statement. They added that the initiative will accelerate the training of laboratory technicians in in vitro diagnostics and expand the trained laboratory workforce.

Specifically, the partnership will focus on developing competency and certification for laboratory human resources for health; developing pre-service training curricula; improving laboratory services, an effort that will include certification courses for pathologists, molecular diagnostics, and quality management; and collaborating with the African Society for Laboratory Medicine to improve local capacity and "promote country ownership and sustainability."

PEPFAR's contribution to the partnership will be implemented through the US Centers for Disease Control and Prevention.

"Strengthening laboratory systems is a priority for PEPFAR because 50-70 percent of clinical decisions depend on accurate laboratory diagnosis," United States Global AIDS Coordinator Eric Goosby said in a statement. "The dramatic scale-up of anti-retroviral treatment requires strengthening partner countries' laboratory systems, molecular diagnostics and monitoring, and human resources."

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.